Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Rasagiline Mesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,746Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Macleods Pharms's Generic Rasagiline Mesylate Receives Approval In US
    Macleods Pharms's Generic Rasagiline Mesylate Receives Approval In US

    28 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208866

    FDA
    28 Jun 2024
    Share Share
    SKG Pharma's Rasagiline Mesylate Receives Approval In the US
    SKG Pharma's Rasagiline Mesylate Receives Approval In the US

    09 Apr 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218163

    FDA
    09 Apr 2024
    Share Share
    Enforcement Report - Week of September 27, 2023
    Enforcement Report - Week of September 27, 2023

    27 Sep 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-27-2023-3225.pdf

    FDA
    27 Sep 2023
    Share Share
    Enforcement Report - Week of January 25, 2023
    Enforcement Report - Week of January 25, 2023

    25 Jan 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf

    FDA
    25 Jan 2023
    Share Share
    Dr. Reddy`s Generics Rasagiline Mesylate Receives Approval in US
    Dr. Reddy`s Generics Rasagiline Mesylate Receives Approval in US

    22 Nov 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201942

    FDA
    22 Nov 2021
    Share Share
    Indoco Remedies Generic Rasagiline Receives Approval in US
    Indoco Remedies Generic Rasagiline Receives Approval in US

    09 Oct 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206153

    FDA
    09 Oct 2019
    Share Share